◆ 会议时间：2026年8月26-29日
◆ 会议地点：澳大利亚 布里斯班

◆ 会议简介：

2026年第8届国际头颈肿瘤学会联盟(IFHNOS)世界大会将于2026年8月26-29日在澳大利亚布里斯班举行。

国际头颈肿瘤学会联盟(IFHNOS)由美国纪念斯隆-凯特琳癌症中心(MSKCC)头颈外科主任Jatin P. Shah于1987年组织建立，现已发展成为一个代表全球65个国家和区域的53个头颈肿瘤专业组织成员的全球性组织。IFHNOS的宗旨是为从事头颈部癌症领域的专家提供一个互动的平台，加强信息交流，提高知识，探索头颈癌患者诊断、治疗和康复的新方向。IFHNOS自1997年开始每4年举办一次世界大会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

IFHNOS 2026 - 8th World Congress of the International Federation of Head and Neck Oncologic Societies

Date:
26 – 29 August 2026

Venue:
Brisbane Convention and Exhibition Centre
Brisbane, Australia

The theme of the congress is “Global Harmonisation of Head and Neck Cancer Care”.

Dear Colleagues,
 
The 8th IFHNOS World Congress will be held in Brisbane, Australia, in August 2026, in collaboration with the Australian and New Zealand Head and Neck Cancer Society. The Congress will be centered around the theme "Global Harmonization of Head and Neck Cancer Care through international collaboration."
 
Brisbane city and the Southbank precinct, the site of the conference venue, is an ideal location for a meeting. Brisbane has a relaxed subtropical feel, while at the same time it has all the facilities, restaurants and entertainment venues that will make it a memorable experience for delegates, accompanying partners and families.
 
There is a real vibrancy to the city as it prepares to host the 2032 Summer Olympic Games and is the gateway to many of the places people love to visit when in Australia such as the Gold Coast and Great Barrier Reef. 
 
IFHNOS is made up of over 70 member societies across 58 countries, and so this will truly be an engaging international head and neck cancer conference for the ages. Along with the organising team, we plan to deliver an exciting 3 days of a high quality scientific and social program. 
 
I do hope you can join us and contribute to what I anticipate will be one of the most successful IFHNOS meetings of all time. I look forward to welcoming you to Australia.
 
Sandro V Porceddu
Convener
IFHNOS 8th World Congress 2026

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。